IPCM pays 70% of revenue to hospitalist and keeps 30% which encourages the doctors to see more patients.I feel there will be a slowdown in elective surgeries as people postpone medical care because of costs.This may slow IPCM growth down but I cant quantify this.Stock looks fully valued around 18-19 at this point.I am waiting on earnings and conference call to re-enter